Filters
reset allOther countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
ATP1A2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics United States | 345 | 159 |
|
Invitae Familial Hemiplegic Migraine Panel Invitae United States | 21 | 7 |
|
Familial Hemiplegic Migraine: gene sequence and deletion/duplication Ambry Genetics United States | 7 | 7 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Wole Exome Sequencing for Hemiplegic Migraine, Epilepsy, Ataxia, CADASIL/Small Vessel Disease Genomics Research Centre Queensland University of Technology Australia | 12 | 4 |
|
Next Generation Sequencing for FHM, EA2, SCA6, CADASIL, Epilepsy Genomics Research Centre Queensland University of Technology Australia | 9 | 4 |
|
Familial Hemiplegic Migraine and Alternating Hemiplegia of Childhood Panel PreventionGenetics United States | 13 | 8 |
|
Familial Hemiplegic Migraine 2 (FHM2) via the ATP1A2 Gene PreventionGenetics United States | 1 | 1 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 4 | 1 |
|
Migraine panel. NGS panel of 10 genes. Genologica Medica Spain | 30 | 10 |
|
Familial Hemiplegic Migraine (NGS Panel and Copy Number Analysis + mtDNA) MNG Laboratories (Medical Neurogenetics, LLC.) United States | 4 | 6 |
|
Asper Biogene Asper Biogene LLC Estonia | 28 | 13 |
|
GeneDx United States | 11 | 4 |
|
CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 132 | 83 |
|
ATP1A2 Full Gene Sequencing Analysis MNG Laboratories (Medical Neurogenetics, LLC.) United States | 2 | 1 |
|
Fulgent Genetics United States | 354 | 209 |
|
Fulgent Genetics United States | 509 | 275 |
|
Adolescent/Adult Epilepsy NGS Panel Fulgent Genetics United States | 182 | 82 |
|
Familial Hemiplegic Migraine , Panel Massive Sequencing (NGS) 6 Genes Reference Laboratory Genetics Spain | 8 | 6 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.